Poland· PL-100387390
Crusia
A enoxaparin product containing enoxaparinum natricum, registered in Poland by Laboratorios Farmaceuticos Rovi, S.A.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Enoxaparin is registered in 16 of 19 countries.
Countries holding a registration under ATC B01AB05 (enoxaparin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Enoxaparin · ATC B01AB05
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Enoxaparinum natricum
- Manufacturer
- Laboratorios Farmaceuticos Rovi, S.A.
- Country
- Poland (PL)
- ATC code
- B01AB05
- ATC class
- Enoxaparin
- Defined daily dose
- 2 TSD, E
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05909991369088
- gtin05909991369095
- gtin05909991378622
- gtin05909991378639
- gtin05909991393007
- gtin05909991393014
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
203 interactions on record for enoxaparin.
Graded by severity as the source publishes them — 106 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Enoxaparin · interactions on record
203 records
- 106 severe
- 73 moderate
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Antithrombin IIIB01AB02severe
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Enoxaparin in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomArovi 120mg/0.8ml solution for injection pre-filled syringesROVI Biotech Ltd
- SwitzerlandClexane
- ItalyCLEXANE T*10 siringhe SC 10.000 UI 1 mlSANOFI Srl
- FranceENOXAPARINE ARROW 10 000 UI (100 mg)/1 mL, solution injectable en seringue préremplieARROW GENERIQUES
- SpainCLEXANE 10.000 UI (100 mg)/ 1 ml SOLUCION INYECTABLE EN JERINGA PRECARGADASanofi Aventis S.A.
- NetherlandsEnoxaparine Becat 10.000 IE (100 mg)/1 ml oplossing voor injectie in een voorgevulde spuitLaboratorios Farmaceuticos Rovi, S.A.
- IcelandEnoxaparin LedraxenVENIPHARM
- SwedenEnoxaparin Ledraxen 10 000 IE (100 mg)/1 ml Injektionsvätska, lösning i förfylld sprutaVENIPHARM
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bdbc51ed-5e78-4448-bcd2-c3c85da4e0e9 GET /v1/drugs/bdbc51ed-5e78-4448-bcd2-c3c85da4e0e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań w ampułko-strzykawce",
"source": "urpl",
"strength": "120 mg/0,8 ml (12 000 j.m.)",
"packaging": "05909991369088 ¦ Rp ¦ 127592\n10 amp.-strzyk. z zabezpieczeniem\n05909991369095 ¦ Rp ¦ 127593\n30 amp.-strzyk. z zabezpieczeniem\n05909991378622 ¦ Rp ¦ 128934\n10 amp.-strzyk. \n05909991378639 ¦ Rp ¦ 128935\n30 amp.-strzyk. \n05909991393007 ¦ Rp ¦ 131022\n50 amp.-strzyk. z zabezpieczeniem\n05909991393014 ¦ Rp ¦ 131023\n50 amp.-strzyk.",
"substance": "Enoxaparinum natricum 120 mg/0,8 ml",
"common_name": "Enoxaparinum natricum",
"pl_product_id": "100387390",
"pozwolenie_nr": "24835",
"auth_procedure": "DCP",
"authorisation_validity": "2024-12-17"
}See everything about enoxaparin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.